NCT00884884View on ClinicalTrials.gov

Aripiprazole and Topiramate on Free-Choice Alcohol Use

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Alcohol Dependence
Interventions
DRUG

Double Placebo

1 capsule daily

DRUG

Aripiprazole 15, placebo

15 mg Aripiprazole daily plus placebo daily

DRUG

Aripiprazole 7.5, Placebo

Aripiprazole 7.5 mg daily plus Placebo daily

DRUG

Topiramate 100, Placebo

Topiramate 100 mg daily plus Placebo daily

DRUG

Topiramate 200, Placebo

Topiramate 200 mg daily plus Placebo daily

DRUG

Topiramate 100, Aripiprazole 15

Topiramate 100 mg daily plus Aripiprazole 15mg daily

DRUG

Topiramate 100, Aripiprazole 7.5

Topiramate 100 mg daily plus Aripiprazole 7.5mg daily

DRUG

Topiramate 100, Aripiprazole 15mg

Topiramate 100 mg daily plus Aripiprazole 15mg daily

DRUG

Topiramate 200, Aripiprazole 7.5mg

Topiramate 200 mg daily plus Aripiprazole 7.5mg daily

DRUG

Topiramate 200, Aripiprazole 15

Topiramate 200mg daily plus Aripiprazole 15mg daily

Trial Locations (1)

02903

Brown University Center for Addiction Studies, Providence

Sponsors

Collaborators (1)

Brown University
All Listed Sponsors
collaborator

Brown University

OTHER

lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH